ACTIVE LEARNING TEMPLATE: Medication
STUDENT NAME _____________________________________
heparin (Porcine)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
anticoagulants ; antithrombotics
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Interferes with blood coagulation by blocking Prophylaxis and treatment of thromboembolic disorders and
thromboembolic
conversion of prothrombin to thrombin and complications associated with atrial fibrillation; anticoagulant
fibrinogen to fibrin. for extracorporeal
and dialysis procedures; maintain patency of IV devices.
Complications Medication Administration
GI: drug-induced hepatitis. Derm: alopecia (long-term Subcutaneous
Used in low-dose therapy.
use), rashes, urticaria. Hemat: bleeding, anemia, After withdrawal of heparin from vial,
thrombocytopenia change needle before injection (prevents
leakage along needle track).
Inject above iliac crest or in abdominal fat
layer. Do not inject within 2 inches
of umbilicus or any scar tissue.
Contraindications/Precautions
History of heparin-induced low blood platelets
(thrombocytopenia)
Uncontrolled, active bleeding (except DIC) Nursing Interventions
Conditions in which coagulation tests cannot be performed Obtain CBC, PT/INR, aPTT.
at appropriate intervals Cross-check dose with co-worker.
Assess for bleeding risk. Question
history of recent trauma, head injuries,
GI/GU bleeding.
Ensure that pt has not received spinal
Interactions anesthesia, spinal procedures.
DRUG: Other anticoagulants (e.g., dabigatran, warfarin), platelet
aggregation inhibitors (e.g., aspirin, clopidogrel), thrombolytics (e.g., tissue
plasminogen activator [TPA]) may increase risk of bleeding.
HERBAL: Cat's claw, dong quai, evening primrose, feverfew, garlic, ginkgo,
ginseng, horsechestnut, red clover have additional antiplatelet activity.
Client Education
Use electric razor, soft toothbrush to
prevent bleeding.
Report red or dark urine, black or red stool,
Evaluation of Medication Effectiveness coffee-ground vomitus, bloodtinged mucus
from cough, signs of stroke, nosebleeds, or
Prevents further extension of existing thrombi or new clot increase in menstruation.
formation. No effect on existing clots. Do not use any OTC medication without
physician approval (may interfere
with platelet aggregation).
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
STUDENT NAME _____________________________________
heparin (Porcine)
MEDICATION __________________________________________________________________________ REVIEW MODULE CHAPTER ___________
anticoagulants ; antithrombotics
CATEGORY CLASS ______________________________________________________________________
PURPOSE OF MEDICATION
Expected Pharmacological Action Therapeutic Use
Interferes with blood coagulation by blocking Prophylaxis and treatment of thromboembolic disorders and
thromboembolic
conversion of prothrombin to thrombin and complications associated with atrial fibrillation; anticoagulant
fibrinogen to fibrin. for extracorporeal
and dialysis procedures; maintain patency of IV devices.
Complications Medication Administration
GI: drug-induced hepatitis. Derm: alopecia (long-term Subcutaneous
Used in low-dose therapy.
use), rashes, urticaria. Hemat: bleeding, anemia, After withdrawal of heparin from vial,
thrombocytopenia change needle before injection (prevents
leakage along needle track).
Inject above iliac crest or in abdominal fat
layer. Do not inject within 2 inches
of umbilicus or any scar tissue.
Contraindications/Precautions
History of heparin-induced low blood platelets
(thrombocytopenia)
Uncontrolled, active bleeding (except DIC) Nursing Interventions
Conditions in which coagulation tests cannot be performed Obtain CBC, PT/INR, aPTT.
at appropriate intervals Cross-check dose with co-worker.
Assess for bleeding risk. Question
history of recent trauma, head injuries,
GI/GU bleeding.
Ensure that pt has not received spinal
Interactions anesthesia, spinal procedures.
DRUG: Other anticoagulants (e.g., dabigatran, warfarin), platelet
aggregation inhibitors (e.g., aspirin, clopidogrel), thrombolytics (e.g., tissue
plasminogen activator [TPA]) may increase risk of bleeding.
HERBAL: Cat's claw, dong quai, evening primrose, feverfew, garlic, ginkgo,
ginseng, horsechestnut, red clover have additional antiplatelet activity.
Client Education
Use electric razor, soft toothbrush to
prevent bleeding.
Report red or dark urine, black or red stool,
Evaluation of Medication Effectiveness coffee-ground vomitus, bloodtinged mucus
from cough, signs of stroke, nosebleeds, or
Prevents further extension of existing thrombi or new clot increase in menstruation.
formation. No effect on existing clots. Do not use any OTC medication without
physician approval (may interfere
with platelet aggregation).
ACTIVE LEARNING TEMPLATES THERAPEUTIC PROCEDURE A7
